-
1
-
-
0026343873
-
Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E
-
Adams Jr JD, Klaidman LK, Odunze IN, Shen HC, Miller CA. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol 1991;14:213-26.
-
(1991)
Mol Chem Neuropathol
, vol.14
, pp. 213-226
-
-
Adams Jr., J.D.1
Klaidman, L.K.2
Odunze, I.N.3
Shen, H.C.4
Miller, C.A.5
-
2
-
-
78649722214
-
Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice
-
Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, et al. Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Eur J Pharmacol 2011;650: 240-8.
-
(2011)
Eur J Pharmacol
, vol.650
, pp. 240-248
-
-
Allami, N.1
Javadi-Paydar, M.2
Rayatnia, F.3
Sehhat, K.4
Rahimian, R.5
Norouzi, A.6
-
3
-
-
0035661219
-
Pioglitazone: A review of Japanese clinical studies
-
Baba S. Pioglitazone: a review of Japanese clinical studies. Curr Med Res Opin 2001;17: 166-89.
-
(2001)
Curr Med Res Opin
, vol.17
, pp. 166-189
-
-
Baba, S.1
-
4
-
-
77954086355
-
Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats
-
Baraka A, ElGhotny S. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats. Eur J Pharmacol 2010;641:123-7.
-
(2010)
Eur J Pharmacol
, vol.641
, pp. 123-127
-
-
Baraka, A.1
ElGhotny, S.2
-
5
-
-
0029924670
-
Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation spatial memory in awake, freely moving rats
-
Barnes CA, Danysz W, Parsons CG. Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation spatial memory in awake, freely moving rats. Eur J Neurosci 1996;8:565-71.
-
(1996)
Eur J Neurosci
, vol.8
, pp. 565-571
-
-
Barnes, C.A.1
Danysz, W.2
Parsons, C.G.3
-
7
-
-
70349841991
-
Scopolamine-induced deficits in cognitive performance: A review of animal studies
-
Blokland A. Scopolamine-induced deficits in cognitive performance: a review of animal studies. Scopolamine Rev 2005:1-76.
-
(2005)
Scopolamine Rev
, pp. 1-76
-
-
Blokland, A.1
-
8
-
-
4043167111
-
A detailed analysis of rats' spatial memory in a probe trial of a Morris task
-
Blokland A, Geraerts E, Been M. A detailed analysis of rats' spatial memory in a probe trial of a Morris task. Behav Brain Res 2004;154:71-5.
-
(2004)
Behav Brain Res
, vol.154
, pp. 71-75
-
-
Blokland, A.1
Geraerts, E.2
Been, M.3
-
9
-
-
0036326074
-
Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
-
Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC. Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease. J Neurochem 2002;82:615-24.
-
(2002)
J Neurochem
, vol.82
, pp. 615-624
-
-
Breidert, T.1
Callebert, J.2
Heneka, M.T.3
Landreth, G.4
Launay, J.M.5
Hirsch, E.C.6
-
10
-
-
25444532519
-
Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes
-
Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV. Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes. Clin Pharmacol 2005;45:1137-44.
-
(2005)
Clin Pharmacol
, vol.45
, pp. 1137-1144
-
-
Christensen, M.L.1
Meibohm, B.2
Capparelli, E.V.3
Velasquez-Mieyer, P.4
Burghen, G.A.5
Tamborlane, W.V.6
-
11
-
-
77957326921
-
Oxidative stress and its implications for future treatments and management of Alzheimer disease
-
Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, et al. Oxidative stress and its implications for future treatments and management of Alzheimer disease. Int J Biomed Sci 2010;6:225-7.
-
(2010)
Int J Biomed Sci
, vol.6
, pp. 225-227
-
-
Clark, T.A.1
Lee, H.P.2
Rolston, R.K.3
Zhu, X.4
Marlatt, M.W.5
Castellani, R.J.6
-
12
-
-
29844458758
-
Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion
-
Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 2006;530:70-80.
-
(2006)
Eur J Pharmacol
, vol.530
, pp. 70-80
-
-
Collino, M.1
Aragno, M.2
Mastrocola, R.3
Gallicchio, M.4
Rosa, A.C.5
Dianzani, C.6
-
13
-
-
0033839006
-
Focal inflammation in the brain, role in Alzheimer's disease
-
Cooper NR, Bradt BM, O'Barr S, Yu JX. Focal inflammation in the brain, role in Alzheimer's disease. Immunol Res 2000;21:159-65.
-
(2000)
Immunol Res
, vol.21
, pp. 159-165
-
-
Cooper, N.R.1
Bradt, B.M.2
O'Barr, S.3
Yu, J.X.4
-
14
-
-
33748755428
-
Therapeutic rescue of neurodegeneration in experimental type 3 diabetes, relevance to Alzheimer's disease
-
de la Monte SM, Tong M, Lester-Coll N, Plater Jr M, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes, relevance to Alzheimer's disease. J Alzheimers Dis 2006;10:89-109.
-
(2006)
J Alzheimers Dis
, vol.10
, pp. 89-109
-
-
De La Monte, S.M.1
Tong, M.2
Lester-Coll, N.3
Plater Jr., M.4
Wands, J.R.5
-
15
-
-
0028799250
-
Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease
-
Dournaud P, Delaere P, Hauw JJ, Epelbaum J. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease. Neurobiol Aging 1995;16:817-23.
-
(1995)
Neurobiol Aging
, vol.16
, pp. 817-823
-
-
Dournaud, P.1
Delaere, P.2
Hauw, J.J.3
Epelbaum, J.4
-
16
-
-
79958252464
-
The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation
-
Dumas JA, Newhouse PA. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav 2011;99:254-61.
-
(2011)
Pharmacol Biochem Behav
, vol.99
, pp. 254-261
-
-
Dumas, J.A.1
Newhouse, P.A.2
-
18
-
-
3042934967
-
Tissue sulfhydryl groups
-
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
-
(1959)
Arch Biochem Biophys
, vol.82
, pp. 70-77
-
-
Ellman, G.L.1
-
19
-
-
0345708155
-
Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine
-
El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary EES. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 2003;76: 523-33.
-
(2003)
Pharmacol Biochem Behav
, vol.76
, pp. 523-533
-
-
El-Sherbiny, D.A.1
Khalifa, A.E.2
Attia, A.S.3
Eldenshary, E.E.S.4
-
20
-
-
12344319426
-
Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms
-
Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, et al. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 2005;374:222-6.
-
(2005)
Neurosci Lett
, vol.374
, pp. 222-226
-
-
Fan, Y.1
Hu, J.2
Li, J.3
Yang, Z.4
Xin, X.5
Wang, J.6
-
21
-
-
0036260784
-
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis
-
Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, et al. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol 2002;51:694-702.
-
(2002)
Ann Neurol
, vol.51
, pp. 694-702
-
-
Feinstein, D.L.1
Galea, E.2
Gavrilyuk, V.3
Brosnan, C.F.4
Whitacre, C.C.5
Dumitrescu-Ozimek, L.6
-
22
-
-
33845328844
-
Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
-
Forero DA, Casadesus G, Perry G, Arboleda H. Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. J Cell Mol Med 2006;10:796-805.
-
(2006)
J Cell Mol Med
, vol.10
, pp. 796-805
-
-
Forero, D.A.1
Casadesus, G.2
Perry, G.3
Arboleda, H.4
-
23
-
-
78651322583
-
A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer's disease
-
Geldmacher DS, Fritsch T, McClendon MJ, Landreth G. A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer's disease. Arch Neurol 2011;68:45-50.
-
(2011)
Arch Neurol
, vol.68
, pp. 45-50
-
-
Geldmacher, D.S.1
Fritsch, T.2
McClendon, M.J.3
Landreth, G.4
-
25
-
-
58149265311
-
Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus
-
Hanyu H, Sato T, Kiuchi A, Sakurai H, Iwamoto T. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus. J Am Geriatr Soc 2009;57:177-9.
-
(2009)
J Am Geriatr Soc
, vol.57
, pp. 177-179
-
-
Hanyu, H.1
Sato, T.2
Kiuchi, A.3
Sakurai, H.4
Iwamoto, T.5
-
27
-
-
44249127445
-
Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolaminetreated mice
-
Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolaminetreated mice. Eur J Pharmacol 2008;588:78-84.
-
(2008)
Eur J Pharmacol
, vol.588
, pp. 78-84
-
-
Jeong, E.J.1
Lee, K.Y.2
Kim, S.H.3
Sung, S.H.4
Kim, Y.C.5
-
28
-
-
36949038203
-
The role of peroxisome proliferatoractivated receptor-gamma (PPARgamma) in Alzheimer's disease, therapeutic implications
-
Jiang Q, Heneka M, Landreth GE. The role of peroxisome proliferatoractivated receptor-gamma (PPARgamma) in Alzheimer's disease, therapeutic implications. CNS Drugs 2008;22:1-14.
-
(2008)
CNS Drugs
, vol.22
, pp. 1-14
-
-
Jiang, Q.1
Heneka, M.2
Landreth, G.E.3
-
30
-
-
40449140007
-
Zeatin supplement improves scopolamine-induced memory impairment in mice
-
Kim MJ, Choi SJ, Lim ST, Kim HK, Kim YJ, Yoon HG, et al. Zeatin supplement improves scopolamine-induced memory impairment in mice. Biosci Biotechnol Biochem 2008;72:577-81.
-
(2008)
Biosci Biotechnol Biochem
, vol.72
, pp. 577-581
-
-
Kim, M.J.1
Choi, S.J.2
Lim, S.T.3
Kim, H.K.4
Kim, Y.J.5
Yoon, H.G.6
-
31
-
-
26844468856
-
Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients
-
Klotz L, Schmidt M, Giese T, Sastre M, Knolle P, Klockgether T, et al. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients. J Immunol 2005;175:4948-55.
-
(2005)
J Immunol
, vol.175
, pp. 4948-4955
-
-
Klotz, L.1
Schmidt, M.2
Giese, T.3
Sastre, M.4
Knolle, P.5
Klockgether, T.6
-
32
-
-
69749092934
-
Loganin improves learning and memory impairments induced by scopolamine in mice
-
Kwon SH, Kim HC, Lee SY, Jang CG. Loganin improves learning and memory impairments induced by scopolamine in mice. Eur J Pharmacol 2009;619:44-9.
-
(2009)
Eur J Pharmacol
, vol.619
, pp. 44-49
-
-
Kwon, S.H.1
Kim, H.C.2
Lee, S.Y.3
Jang, C.G.4
-
33
-
-
0035693506
-
Anti-inflammatory actions of peroxisome proliferatoractivated receptor gamma agonists in Alzheimer's disease
-
Landreth GE, Heneka MT. Anti-inflammatory actions of peroxisome proliferatoractivated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging 2001;22:937-44.
-
(2001)
Neurobiol Aging
, vol.22
, pp. 937-944
-
-
Landreth, G.E.1
Heneka, M.T.2
-
34
-
-
0029125266
-
Free radical involvement in neuropsychiatric illnesses
-
Lohr JB, Browning JA. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol Bull 1995;31:159-65.
-
(1995)
Psychopharmacol Bull
, vol.31
, pp. 159-165
-
-
Lohr, J.B.1
Browning, J.A.2
-
35
-
-
79953203593
-
Comparative cardiovascular effects of thiazolidinediones, systematic review and meta-analysis of observational studies
-
Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones, systematic review and meta-analysis of observational studies. BMJ 2011;342: d1309.
-
(2011)
BMJ
, vol.342
-
-
Loke, Y.K.1
Kwok, C.S.2
Singh, S.3
-
36
-
-
20444398490
-
Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation
-
Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martínez A, Perez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem 2005;280:21453-62.
-
(2005)
J Biol Chem
, vol.280
, pp. 21453-21462
-
-
Luna-Medina, R.1
Cortes-Canteli, M.2
Alonso, M.3
Santos, A.4
Martínez, A.5
Perez-Castillo, A.6
-
37
-
-
0031057599
-
Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys
-
Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 1997;47:29-35.
-
(1997)
Arzneimittelforschung
, vol.47
, pp. 29-35
-
-
Maeshiba, Y.1
Kiyota, Y.2
Yamashita, K.3
Yoshimura, Y.4
Motohashi, M.5
Tanayama, S.6
-
38
-
-
3943092621
-
Pathways towards and away from Alzheimer's disease
-
Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004;430: 631-9.
-
(2004)
Nature
, vol.430
, pp. 631-639
-
-
Mattson, M.P.1
-
39
-
-
34548077338
-
Thiazolidinediones, novel treatments for cognitive deficits in mood disorders?
-
McIntyre RS, Soczynska JK, Woldeyohannes HO, Lewis GF, Leiter LA, MacQueen GM, et al. Thiazolidinediones, novel treatments for cognitive deficits in mood disorders? Expert Opin Pharmacother 2007;8:1615-28.
-
(2007)
Expert Opin Pharmacother
, vol.8
, pp. 1615-1628
-
-
McIntyre, R.S.1
Soczynska, J.K.2
Woldeyohannes, H.O.3
Lewis, G.F.4
Leiter, L.A.5
MacQueen, G.M.6
-
40
-
-
0028214720
-
Delayed emergence of effects of memory-enhancing drugs, implications for the dynamics of long-term memory
-
Mondadori C, Hengerer B, Ducret T, Borkowski J. Delayed emergence of effects of memory-enhancing drugs, implications for the dynamics of long-term memory. Proc Natl Acad Sci 1994;91:2041-5.
-
(1994)
Proc Natl Acad Sci
, vol.91
, pp. 2041-2045
-
-
Mondadori, C.1
Hengerer, B.2
Ducret, T.3
Borkowski, J.4
-
41
-
-
77951810969
-
Causes versus effects, the increasing complexities of Alzheimer's disease pathogenesis
-
Mondragón-Rodríguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, et al. Causes versus effects, the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother 2010;10:683-91.
-
(2010)
Expert Rev Neurother
, vol.10
, pp. 683-691
-
-
Mondragón-Rodríguez, S.1
Basurto-Islas, G.2
Lee, H.G.3
Perry, G.4
Zhu, X.5
Castellani, R.J.6
-
42
-
-
77449159407
-
Detection and localization of markers of oxidative stress by in situ methods: Application in the study of Alzheimer disease
-
Moreira PI, Sayre LM, Zhu X, Nunomura A, Smith MA, Perry G. Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. Methods Mol Biol 2010;610:419-34.
-
(2010)
Methods Mol Biol
, vol.610
, pp. 419-434
-
-
Moreira, P.I.1
Sayre, L.M.2
Zhu, X.3
Nunomura, A.4
Smith, M.A.5
Perry, G.6
-
43
-
-
0021173996
-
Developments of a water-maze procedure for studying spatial learning in the rat
-
Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47-60.
-
(1984)
J Neurosci Methods
, vol.11
, pp. 47-60
-
-
Morris, R.1
-
44
-
-
55249125525
-
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist
-
Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, et al. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 2008;28:9287-96.
-
(2008)
J Neurosci
, vol.28
, pp. 9287-9296
-
-
Nicolakakis, N.1
Aboulkassim, T.2
Ongali, B.3
Lecrux, C.4
Fernandes, P.5
Rosa-Neto, P.6
-
45
-
-
77955285732
-
Rosiglitazone revisited, an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality
-
Nissen SE, Wolski K. Rosiglitazone revisited, an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med 2010;170: 1191-201.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1191-1201
-
-
Nissen, S.E.1
Wolski, K.2
-
46
-
-
0018384650
-
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
-
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
-
(1979)
Anal Biochem
, vol.95
, pp. 351-358
-
-
Ohkawa, H.1
Ohishi, N.2
Yagi, K.3
-
47
-
-
33750454798
-
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats
-
Pathan AR, Viswanad B, Sonkusare SK, Ramarao P. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci 2006;79:2209-16.
-
(2006)
Life Sci
, vol.79
, pp. 2209-2216
-
-
Pathan, A.R.1
Viswanad, B.2
Sonkusare, S.K.3
Ramarao, P.4
-
48
-
-
33745234766
-
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
-
Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 2006;199:265-73.
-
(2006)
Exp Neurol
, vol.199
, pp. 265-273
-
-
Pedersen, W.A.1
McMillan, P.J.2
Kulstad, J.J.3
Leverenz, J.B.4
Craft, S.5
Haynatzki, G.R.6
-
49
-
-
2342420034
-
Lipid peroxidation and oxidative imbalance, early functional events in Alzheimer's disease
-
Pratico D, Sung S. Lipid peroxidation and oxidative imbalance, early functional events in Alzheimer's disease. J Alzheimers Dis 2004;6:171-5.
-
(2004)
J Alzheimers Dis
, vol.6
, pp. 171-175
-
-
Pratico, D.1
Sung, S.2
-
50
-
-
33745266146
-
Efficacy of rosiglitazone in a genetically defined population with mild-to moderate Alzheimer's disease
-
Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, et al. Efficacy of rosiglitazone in a genetically defined population with mild-to moderate Alzheimer's disease. Pharmacogenomics J 2006;6:246-54.
-
(2006)
Pharmacogenomics J
, vol.6
, pp. 246-254
-
-
Risner, M.E.1
Saunders, A.M.2
Altman, J.F.3
Ormandy, G.C.4
Craft, S.5
Foley, I.M.6
-
51
-
-
23944490153
-
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice
-
Schütz B, Reimann J, Dumitrescu-Ozimek L, Kappes-Horn K, Landreth GE, Schürmann B, et al. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J Neurosci 2005;25:7805-12.
-
(2005)
J Neurosci
, vol.25
, pp. 7805-7812
-
-
Schütz, B.1
Reimann, J.2
Dumitrescu-Ozimek, L.3
Kappes-Horn, K.4
Landreth, G.E.5
Schürmann, B.6
-
52
-
-
79961103714
-
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
-
Swanson CR, Joers V, Bondarenko V, Brunner K, Simmons HA, Ziegler TE, et al. The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflammation 2011;8:91.
-
(2011)
J Neuroinflammation
, vol.8
, pp. 91
-
-
Swanson, C.R.1
Joers, V.2
Bondarenko, V.3
Brunner, K.4
Simmons, H.A.5
Ziegler, T.E.6
-
54
-
-
33644592598
-
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone, a preliminary study
-
Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone, a preliminary study. Am J Geriatr Psychiatry 2005;13:950-8.
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 950-958
-
-
Watson, G.S.1
Cholerton, B.A.2
Reger, M.A.3
Baker, L.D.4
Plymate, S.R.5
Asthana, S.6
|